Chargement en cours...
Pentoxifylline decreases oxidized lipid products in nonalcoholic steatohepatitis: New evidence on the potential therapeutic mechanism
BACKGROUND: Pentoxifylline (PTX) improved histological features of nonalcoholic steatohepatitis (NASH) in a recent randomized placebo-controlled trial. However, the underlying mechanism responsible for the beneficial effects of PTX in NASH remains unidentified. A key role of lipid oxidation in the p...
Enregistré dans:
| Auteurs principaux: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2012
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3430813/ https://ncbi.nlm.nih.gov/pubmed/22505276 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.25778 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|